The Clorox Company
CLX
$117.61
-$0.16-0.14%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.67B | 1.43B | 1.99B | 1.67B | 1.69B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.67B | 1.43B | 1.99B | 1.67B | 1.69B |
| Cost of Revenue | 951.00M | 833.00M | 1.06B | 926.00M | 950.00M |
| Gross Profit | 722.00M | 596.00M | 924.00M | 742.00M | 736.00M |
| SG&A Expenses | 452.00M | 444.00M | 469.00M | 477.00M | 467.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 6.00M | 5.00M | 6.00M | -3.00M | 4.00M |
| Total Operating Expenses | 1.44B | 1.31B | 1.57B | 1.43B | 1.45B |
| Operating Income | 235.00M | 119.00M | 417.00M | 241.00M | 234.00M |
| Income Before Tax | 215.00M | 107.00M | 410.00M | 254.00M | 237.00M |
| Income Tax Expenses | 54.00M | 25.00M | 74.00M | 63.00M | 43.00M |
| Earnings from Continuing Operations | 161.00M | 82.00M | 336.00M | 191.00M | 194.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.00M | -2.00M | -4.00M | -5.00M | -1.00M |
| Net Income | 157.00M | 80.00M | 332.00M | 186.00M | 193.00M |
| EBIT | 235.00M | 119.00M | 417.00M | 241.00M | 234.00M |
| EBITDA | 290.00M | 175.00M | 467.00M | 296.00M | 287.00M |
| EPS Basic | 1.29 | 0.65 | 2.70 | 1.51 | 1.56 |
| Normalized Basic EPS | 1.06 | 0.48 | 1.99 | 1.08 | 1.07 |
| EPS Diluted | 1.29 | 0.65 | 2.69 | 1.50 | 1.55 |
| Normalized Diluted EPS | 1.05 | 0.48 | 1.98 | 1.07 | 1.06 |
| Average Basic Shares Outstanding | 121.60M | 122.63M | 123.17M | 123.37M | 123.77M |
| Average Diluted Shares Outstanding | 121.92M | 123.02M | 123.74M | 124.07M | 124.66M |
| Dividend Per Share | -- | 1.24 | 1.24 | 1.22 | 1.22 |
| Payout Ratio | 96.18% | 188.75% | 45.18% | 80.65% | 78.24% |